GL vs JANX · P/E 10, rev $3.16B vs rev $10.3M
Globe Life Inc (GL) versus Janux Therapeutics Inc (JANX) — a side-by-side from cached financials, not a winner call.
Globe Life Inc (GL) is a insurance - life company listed on US.
Janux Therapeutics Inc (JANX) is a biotechnology company listed on US.
Latest reported GL revenue for 2026-06-30 was $3.16B. Net income was $558.3M. GL currently screens at market cap $10.26B and trailing P/E 10.1.
Latest reported JANX revenue for 2026-06-30 was $10.3M. Net income was -$22.0M. JANX currently screens at market cap $1.49B.
GL currently screens at market cap $10.26B and trailing P/E 10.1. JANX currently screens at market cap $1.49B.
Not investment advice. Open the GL and JANX stock pages for the full models.
Not investment advice.